Clinical Study

In a breakthrough that reshapes the understanding of immune system dynamics, researchers from the Technical University of Munich (TUM) and Helmholtz Munich have identified that the human body begins preparing for severe disease scenarios far earlier than previously believed. Even in cases of mild or moderate infections, the body produces a subset of T cells predisposed to exhaustion—a phenomenon previously associated only with chronic infections and tumors.

Pancreatic cancer is one of the deadliest forms of cancer, and it’s on track to become even more lethal. By 2030, it is projected to be the second-leading cause of cancer deaths globally. Often diagnosed at a late stage, the disease is notoriously difficult to treat, with survival rates remaining dismally low despite decades of research.

Dietary changes could reduce the pain of endometriosis for half of those living with the disease, a major new international study suggests.

A recent randomized controlled trial published in the journal Nutrients has found that pomegranate extract (PE) supplementation may offer significant health benefits to adults over the age of 55, particularly in reducing systolic blood pressure and key markers of inflammation. This research contributes to the growing body of evidence supporting the use of non-pharmaceutical strategies to promote healthy ageing.

A new study from the University of Jyväskylä in Finland reveals that the everyday physical activities most women engage in are insufficient to counteract the accelerated bone loss driven by hormonal changes during menopause. Researchers warn that while regular movement is beneficial for overall health, the typical impacts of daily life do not provide the targeted bone-loading necessary to slow the weakening of bones that accompanies the menopausal transition.

Breast cancer is the most common cancer among women worldwide, and early detection and treatment have significantly boosted survival rates. With five-year survival at 91% and ten-year survival at 85%, millions of women are now living as breast cancer survivors. However, new research published in Aging reveals that surviving breast cancer comes with a hidden cost: accelerated biological aging. This study, which introduces the concept of Phenotypic Age Acceleration (PAA), examines how both the characteristics of the tumor and the treatments administered may contribute to an increased rate of aging among survivors.